A Complete Guide To Tendon Disorders And Treatment Options

While this is mostly associated with active individuals, tendon disorders can happen to anyone participating in recurring daily activities. This type of injury can affect the everyday functioning of life and the ability to do physical tasks because of pain, discomfort, and reduced mobility. Fortunately, effective therapies can treat the many types of tendon conditions […]
Terumo Neuro Celebrates 15 Years of the WEB Device: A Game-Changing Innovation in Aneurysm Treatment
Carsten Schroeder, President and CEO of Terumo Neuro, commented on this significant milestone: “The WEB device has set a new standard in aneurysm treatment and has been instrumental in our mission to drive game-changing impact in neurovascular care. With 15 years of proven clinical success, WEB continues to advance patient outcomes, reducing the need for multiple devices and lengthy procedures. As we celebrate this achievement, we remain committed to innovating alongside leading physicians worldwide to shape the future of neurovascular care.”
RenyMed Earns Prestigious EcoVadis Gold Medal for Excellence in Sustainability
This achievement places RenyMed in the top 5% of all companies assessed globally, underscoring its dedication to ethical business practices, environmental stewardship, and workforce well-being.
The Role of Contract Research Organizations in Modern Clinical Research
Contract research organizations assist pharmaceutical, biotechnology, and medical device companies in streamlining their operations while ensuring compliance with regulatory standards.
Michael Andersen Joins Vektor Medical as Vice President, Quality Assurance and Regulatory Affairs
Michael Andersen brings more than 20 years of commercial leadership experience in electrophysiology and medtech, with a strong track record of market development, sales execution, and strategic growth.
Bracco Diagnostics Announces Significant Upgrades to its Innovative HeartSee™ Software
“These improvements underscore our dedication to supporting physicians in making informed decisions that improve patient outcomes. We believe the new features of HeartSee will set a new standard in cardiac care, helping to detect and treat coronary artery disease more effectively and efficiently than ever before,” said Derek Steptoe, Senior Manager of Nuclear Cardiology, Bracco.
SubtleHD Receives CE Mark, Expanding Access to AI-Powered MRI Enhancement Across Europe Reports Subtle Medical
SubtleHD sets a new benchmark in image quality and speed for European MRI providers.
10 High-Tech Solutions to Enhance Seniors’ Daily Lives

As technology advances, so do the tools designed to enhance the lives of older adults. Many innovative products cater specifically to seniors, offering solutions that improve safety, independence, and overall well-being. Whether a senior is living alone or receiving home care in Bellevue, WA, these advanced tools can provide vital support for daily activities. 1. […]
Preparing for the Logistical Complexities Presented by Personalized Medicine | By Tim McClatchy, VP Life Sciences at Kenco

With the right mix of planning, monitoring and data management, carriers can successfully deliver the tools and treatments that make the personalized medicine revolution possible.
Smart Reactors: Revolutionizing Medical Device Coatings with Innovative Biocompatibility Solutions
Smart Reactors, an innovative medical technology company with headquarters in Ireland, is addressing this challenge head-on with its groundbreaking Camouflage™ coating technology.
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
Guido Baechler, CEO of Mainz Biomed: “Securing the exclusive rights to license this portfolio of novel biomarkers is a major milestone and extension of our previously announced PancAlert program. It provides us with an extraordinary opportunity in the early detection and diagnosis of one of the most challenging cancers to treat. We believe that this achievement marks a paradigm shift in how we can detect pancreatic cancer.”
Medigene Submits Patent for Unique NK-Specific TCR Construct with European Patent Office
“This innovative approach supports our strategy to apply Medigene’s 3S TCRs into new TCR-guided modalities, such as TCR-TCEs and now TCR-NKs, to create additional value for both patients and our shareholders,” said Selwyn Ho, CEO of Medigene. “Expanding our TCR-guided therapies to include NK cells aligns with our commitment to developing off-the-shelf, highly specific, and effective immunotherapies for cancer treatment.”